Cargando…
Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
CONTEXT: Adrenal insufficiency (AI) is an important medical concern for clinicians when normocortisolemia is achieved during treatment of endogenous Cushing syndrome (CS). OBJECTIVE: To examine symptoms of potential AI in a large population of normocortisolemic patients without CS treated with mifep...
Autores principales: | Yuen, Kevin C. J., Moraitis, Andreas, Nguyen, Dat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686650/ https://www.ncbi.nlm.nih.gov/pubmed/29264481 http://dx.doi.org/10.1210/js.2016-1097 |
Ejemplares similares
-
Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma
por: Ragucci, Enzo, et al.
Publicado: (2017) -
SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019) -
Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
por: Cohan, Pejman
Publicado: (2016) -
Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
por: Cohan, Pejman, et al.
Publicado: (2019) -
No Postoperative Adrenal Insufficiency in a Patient with Unilateral Cortisol-Secreting Adenomas Treated with Mifepristone Before Surgery
por: Saroka, Rachel M., et al.
Publicado: (2016)